-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Scinai Immunotherapeutics Ltd. annual/quarterly Share-based Payment Arrangement, Expense history and growth rate from 2022 to 2024.
- Scinai Immunotherapeutics Ltd. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2023 was $252K, a 48% decline year-over-year.
- Scinai Immunotherapeutics Ltd. annual Share-based Payment Arrangement, Expense for 2024 was $682K, a 40.1% decline from 2023.
- Scinai Immunotherapeutics Ltd. annual Share-based Payment Arrangement, Expense for 2023 was $1.14M, a 28.9% decline from 2022.
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)